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MATERIALS AND METHODSPatients selection for the study was done on clinical parameters of chronic anemia and low-grade fever, splenomegaly, and bicytopenia/pancytopenia on peripheral blood examination. Bone marrow aspiration of such 110 patients was done over a period from January 2015 to November 2017. Age of these patients ranged from 8 years to 54 years. Bone marrow slides were stained with Giemsa stain. 49 Patients out of 110 patients showed the presence of P. vivax parasite in bone marrow aspiration. 11 Patients among these 49 patients showed the presence of hemophagocytosis in bone marrow aspiration.
RESULTSBone marrow aspiration was done in 110 patients over a period from January 2015 to November 2017, who presented with chronic anemia, low-grade fever, splenomegaly, and bicytopenia/pancytopenia. 49 Out of these 110 patients showed the presence of P. vivax parasite in bone marrow aspiration. Further 11 patients of these 49 patients showed the presence of hemophagocytosis in bone marrow aspiration. 9 patients of these 11 patients presented with pancytopenia and 2 patients presented with bicytopenia (anemia and thrombocytopenia). Bone marrow of these 
INTRODUCTIONHemophagocytic syndrome is a reactive disorder of the mononuclear phagocytic system, characterized by histiocytic proliferation with marked hemophagocytosis in the bone marrow. It is related to hematological diseases, autoimmune diseases, or infections such as virus, bacteria, fungi, and parasites. Malaria is one of the most common infectious diseases and a major public health problem. It affects >500 million people causing more than 1 million deaths each year worldwide.[1] The association of pancytopenia in severe malaria due to Plasmodium vivax with the hemophagocytic syndrome is extremely rare and very few cases are reported in the world literature.[2] According to the CDC reports, Plasmodium 
falciparum was listed one of the major causes of hantavirus pulmonary syndrome (HPS), but not P. vivax.[3] Hemophagocytic lymphohistiocytosis (HLH) secondary to infectious disease is an important entity especially in tropics where infectious diseases are rampant and still pose a major threat. A timely diagnosis and prompt treatment can improve the clinical outcome of this potentially fatal outcome.[4-6] The aim is to alert the clinicians that in persistent unresolved fever, a diagnosis of secondary HLH should be given due consideration. We present 11 cases in this series.
ABSTRACT
Background: Hemophagocytic syndrome is a reactive disorder of the mononuclear phagocytic system. The association of 
pancytopenia in severe malaria due to Plasmodium vivax with hemophagocytic syndrome is extremely rare and very few cases are 
reported in the world literature.
Aim: The study was undertaken to establish P. vivax infestation associated with hemophagocytosis in bone marrow as one of the 
causes of chronic pancytopenia/bicytopenia with fever and splenomegaly in endemic areas.
Materials and Methods: Prospective study of 110 patients of different age groups presenting with chronic fever with pancytopenia 
or bicytopenia from January 2015 to November 2017 was carried out. 49 patients showed the presence of P. vivax trophozoites in 
bone marrow. Among these 11 patients showed the presence of hemophagocytosis in bone marrow fulfilling 6 out of 8 criteria of 
diagnosing hemophagocytic lymphohistiocytosis according to 2004 criteria.
Results: The age of patients varied from 8 years to 54 years. 11 Cases showed the presence of P. vivax trophozoites with the presence 
of hemophagocytosis in bone marrow showing, hyperplastic marrow showing normoblastic and megaloblastic hyperplasia.
Conclusion: Hemophagocytic syndrome in malaria should be suspected in all cases of chronic fever with pancytopenia or 
bicytopenia, splenomegaly. Bone marrow aspiration is recommended to confirm the diagnosis of P. vivax as one of the causes of 
the secondary hemophagocytic syndrome in malaria-endemic areas.
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11 patients was hypercellular showing erythroid hyperplasia (late normoblastic and megaloblastic). Serum ferritin levels were raised in all these 11 patients; serum fibrinogen level, however, was within normal range, serum triglycerides was raised along with increased serum levels for serum glutamic-oxaloacetic transaminase and serum glutamic-pyruvic transaminase. In all 11 patients, 6 out of 8 criteria from HLH 2004 criteria were fulfilled.Hemophagocytosis of lymphocytes, polymorphs, and platelets was seen in bone marrow aspiration [Figures 1 and 2].
DISCUSSIONHemo lymphohistiocytosis is a hyperinflammatory condition which may be familial or secondary to autoimmune diseases or infection, malignancy or other triggers.[4,5] It is characterized by proliferation of monocytes or macrophages showing phagocytosis of hematopoietic cells. Malaria due to P. vivax is a very rare cause of pancytopenia associated with hemophagocytic syndrome. The probable pathogenesis of hemophagocytic syndrome in vivax malaria is due to inappropriate or excessive immunological response to T-cells. Excessive pro-inflammatory or defective 
anti-inflammatory responses cause cytokine storm leads to host tissue damage and organ dysfunction associated with the syndrome. There are activation and elaboration of cytokines such as interleukin (IL)-1, IL-2, IL-6, and tumor necrosis factor-alpha by T-helper cells which promote activation of macrophages resulting in phagocytosis of the blood cells. These cytokines cause sequestration, and rapid destruction of the formed blood cells suppresses the proliferation of progenitor cells which aggravate the pancytopenia. High levels of cytokines resolve soon after successful treatment of malaria.[6-8] HLH arising in a patient with the underlying genetic mutation is termed familial HLH, in an underlying rheumatologic disease like rheumatoid arthritis is termed as macrophage activation syndrome and in underlying infection, it is termed as reactive or secondary hemophagocytic syndrome (HPS) or secondary HLH Table 1. The reactive or infection associated HLH remains important and unfortunately underdiagnosed entity especially in the tropical areas; hence, it continues to be a potentially fatal disease.[9] Fever after a brief period of recovery from the first episode, coinciding with the cytopenias, unresponsiveness to broad-spectrum antibiotics, new onset of organomegaly or sudden increase in the size of organomegaly are some of the diagnostic clues for HLH. Even a single value of ferritin more than 10,000 in the absence of iron overload conditions, is a surrogate marker for HLH.[10] Tentative diagnosis of HLH is made based on 2004 HLH protocol. HPS secondary to infections is classified as a separate entity under the international classification of diseases by the World Health Organization[8] virus especially Epstein-Barr virus (EBV), dengue, herpes, cytomegalovirus (CMV), and HIV have been reported to have secondary HPS.[10-15] Secondary, HPS due to bacterial infections such as tuberculosis,[16] salmonella, leptospirosis, malaria, toxoplasmosis, Leishmania, and Rickettsia are also reported.[17,18] There are various case reports and case series of reactive HLH secondary to infectious causes especially in the tropical countries, but still, it remains as an under diagnosed 
Figure 1: Bone marrow, Giemsa stain, ×40 hemophagocytosis of 
lymphocyte
Figure 2: Bone marrow, Giemsa stain, ×40 hemophagocytosis
Table 1: Diagnostic criteria for HLH. According 
to the HLH 2004 protocol
A diagnosis of HLH can be made if either criteria 1 or 2 is met:
Molecular diagnosis consistent with HLH
Clinical and laboratory criteria (at least 5/8 criteria should be fulfilled)
Fever
Splenomegaly
Cytopenia > 2–3 cell lines in peripheral blood (hemoglobin < 9 g/100 ml, 
platelets < 100 × 10/L, neutrophils < 1.0 × 10/L)
Hypertriglyceridemia and/or hypofibrinogenemia (fasting 
triglycerides > 3.0 mmol/L, fibrinogen < 1.5 g/L)
Hemophagocytosis in bone marrow, spleen, CSF, or lymph nodes. No 
sign of malignancy
Decreased or absent NK‑cell activity (according to local laboratory 
reference)
Ferritin > 500 ug/L
sCD25 (soluble IL‑2 receptor) > 2400 U/ml
Supportive evidence includes:
Cerebral symptoms with moderate pleocytosis and/or
Elevated protein
Elevated transaminases
Elevated bilirubin
Elevated LDH
HLH: Hemophagocytic lymphohistiocytosis, CSF: Cerebrospinal fluid, NK: Natural 
killer, IL: Interleukin, LDH: Lactate dehydrogenase
www.apjhs.com Rastogi: Hemophagocytic syndrome
Asian Pacific Journal of Health Sciences  |  Vol. 5 | Issue 1 | January-March | 2018 Page | 33
and under reported entity.[5,11] The treatment of secondary HLH includes aggressive treatment of underlying condition along with immunosuppressive therapy. Clinicians worldwide use the standard HLH 2004 protocol.[18] Most of the infection associated HLH reported to a course of corticosteroids. Rajagopala and Singh in their review of hemophagocytosis trigger as a cause in 51% of the adult patients.[11] Leishmania was seen in 40.6%, Rickettsia in 18.8%, malaria in 15.6%, enteric fever in 9.4%, and viral agents in 30% of cases. In children 56% patients were secondary to the virus, 26% secondary to dengue virus, 17.3% secondary to EBV, and 8.7% each to CMV and parvovirus B19. In India, HLH associated with dengue fever and malaria with high parasitic index has been documented.[19] Both falciparum and vivax have been reported to cause HPS, although malarial infection has been rarely reported to cause secondary HPS.[6,20,21] Ohno et al. had described one of the first cases of hemophagocytosis secondary to malaria (falciparum) which resolved with antimalarials.[6] Park 
et al. reported four cases of HLH secondary to vivax malaria all of which resolved with antimalarials.[22] Studies in the pediatric population show degree of parasitemia is associated with severity of the disease.[19] According to the data till date only 20 patients in 18 studies have been reported having HPS secondary to malaria.[23] In the present series, 11 cases of HLH were diagnosed secondary to P. vivax infection. In our cases, the presence of hemophagocytosis and P. vivax parasite in bone marrow aspiration were in accordance with the current criteria for HPS. Total clinical and hematological recovery after antimalarial treatment rules out the possibility of familial HPS. Hemophagocytosis was observed in the bone marrow of patients with malaria showed erythrophagocytosis, phagocytosis of neutrophils and platelets. Malaria-induced HPS usually responds to antimalarial alone, but rarely steroids have been used. Most of the cases reported in literature have responded completely with antimalarials. Very rarely parasites are not found in peripheral blood smears from patients with malaria, even in severe infections, and are diagnosed based on bone marrow study alone.[24,25] This may be explained by pretreatment with antimalarial drugs in inadequate doses, causing partial clearance of the parasite, low levels of parasitemia not detected by conventional microscopy or by sequestration of the parasitized cells, in deep vascular beds.[25]
CONCLUSIONHemophagocytic syndrome in malaria should be suspected in all the cases of severe and or complicated malaria, especially when anemia does not improve even after antimalarial therapy. A diagnostic bone marrow aspiration is recommended in such cases to confirm the diagnosis. P. vivax should be listed as one of the causes of secondary hemophagocytic syndrome especially in children from malaria-endemic areas. Regular follow-up should be done after antimalarial therapy as prolonged anemia is one of the serious complications.
ACKNOWLEDGMENTSPatient and his relatives.
REFERENCES
1. Krause PJ, Chandy JC. In: Behrman RE, Kleigman RM, 
Stanton BF, Schor NF, St. Geme JW 3rd, editors. 
Malaria (Plasmodium) Nelson Text Book of Paediatrics. 
19th ed. Philadelphia, PA: WB Saunders Company; 2012. 
p. 1198-207.
2. Mohapatra MK, Padhiary KN, Mishra DP, Sethy G. Atypical 
manifestation of Plasmodium vivax malaria. Indian J Malariol 
2002;39:18-25.
3. Fisman DN. Hemophagocytic syndromes and infection. 
Emerg Infect Dis 2000;6:601-8.
4. Canna SW, Behrens EM. Making sense of the cytokine storm: 
A conceptual framework for understanding, diagnosing, and 
treating hemophagocytic syndromes. Pediatr Clin North Am 
2012;59:329-44.
5. Ramos-Casals M, Brito-Zerón P, López-Guillermo A, 
Khamashta MA, Bosch X. Adult haemophagocytic syndrome. 
Lancet 2014;383:1503-16.
6. Ohno T, Shirasaka A, Sugiyama T, Furukawa H. 
Hemophagocytic syndrome induced by Plasmodium 
falciparum malaria infection. Int J Hematol 1996;64:263-6.
7. Sermet-Gaudelus I, Abadie V, Stambouli F, Hennequin C, 
Lenoir G, Gendrel D, et al. Haemophagocytic syndrome 
in Plasmodium falciparum malaria. Acta Paediatr 
2000;89:368-9.
8. Retornaz F, Seux V, Arnoulet C, Durand JM, Sainty D, 
Soubeyrand J, et al. Plasmodium falciparum malaria infection 
complicated by haemophagocytic syndrome in an old man. 
Acta Haematol 2000;103:224-5.
9. Sung L, Weitzman SS, Petric M, King SM. The role of 
infections in primary hemophagocytic lymphohistiocytosis: 
A case series and review of the literature. Clin Infect Dis 
2001;33:1644-8.
10. Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated 
ferritin levels and the diagnosis of hemophagocytic 
lymphohistiocytosis. Pediatr Blood Cancer 2008;50:1227-35.
11. Rajagopala S, Singh N. Diagnosing and treating 
hemophagocytic lymphohistiocytosis in the tropics: 
Systematic review from the Indian subcontinent. Acta Med 
Acad 2012;41:161-74.
12. Larroche C. Hemophagocytic lymphohistiocytosis in adults: 
Diagnosis and treatment. Joint Bone Spine 2012;79:356-61.
13. Créput C, Galicier L, Buyse S, Azoulay E. Understanding 
organ dysfunction in hemophagocytic lymphohistiocytosis. 
Intensive Care Med 2008;34:1177-87.
14. Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH Jr., 
Simmons RL, et al. Virus-associated hemophagocytic 
syndrome: A benign histiocytic proliferation distinct from 
malignant histiocytosis. Cancer 1979;44:993-1002.
15. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, 
Gould C, et al. Infections associated with haemophagocytic 
syndrome. Lancet Infect Dis 2007;7:814-22.
16. Brastianos PK, Swanson JW, Torbenson M, Sperati J, 
Karakousis PC. Tuberculosis-associated haemophagocytic 
syndrome. Lancet Infect Dis 2006;6:447-54.
17. Niller HH. Myelodysplastic syndrome (MDS) as a late stage 
of subclinical hemophagocytic lymphohistiocytosis (HLH): 
A putative role for leptospira infection. A hypothesis. Acta 
Microbiol Immunol Hung 2010;57:181-9.
18. Cascio A, Giordano S, Dones P, Venezia S, Iaria C, Ziino O, 
et al. Haemophagocytic syndrome and rickettsial diseases. 
J Med Microbiol 2011;60:537-42.
19. Ansuini V, Rigante D, Esposito S. Debate around infection-
dependent hemophagocytic syndrome in paediatrics. BMC 
Infect Dis 2013;13:15.
20. Saribeyoglu ET, Anak S, Agaoglu L, Boral O, Unuvar A, 
Devecioglu O, et al. Secondary hemophagocytic 
lymphohistiocytosis induced by malaria infection in a child 
with langerhans cell histiocytosis. Pediatr Hematol Oncol 
2004;21:267-72.
21. Aouba A, Noguera ME, Clauvel JP, Quint L. Hemophagocytic 
syndrome associated with Plasmodium vivax infection. Br J 
Haematol 2000;103:832-3.
Rastogi: Hemophagocytic syndrome www.apjhs.com
Asian Pacific Journal of Health Sciences  |  Vol. 5 | Issue 1 | January-March | 2018Page | 34
22. Park TS, Oh SH, Choi JC, Kim HH, Chang CL, Son HC, 
et al. Plasmodium vivax hemophagocytic syndrome 
in an immunocompetent serviceman. Am J Hematol 
2003;74:127-30.
23. Muthu V, Dhooria S, Sehgal IP, Agarwal R, Behera D, 
Varma N. Malaria associated secondary hemophagocytic 
lymphohistiocytosis. Report of two cases and review of 
literature. Indian J Med Res 2017;145:399-404.
24. Imirzalioglu C, Soydan N, Schaller M, Bretzel RG, 
Chakraborty T, Domann E, et al. Diagnosis of mixed 
Plasmodium malariae and P. Vivax infection in a development 
aid volunteer by examination of bone-marrow specimens by 
real-time PCR. J Clin Microbiol 2006;44:2307-10.
25. Arora S, Gaiha M, Arora A. Role of the parasight-F test in 
the diagnosis of complicated Plasmodium falciparum malarial 
infection. Braz J Infect Dis 2003;7:332-8.
How to cite this Article: Rastogi N. Hemophagocytic syndrome secondary 
to Plasmodium vivax infection - A prospective study of 11 cases. Asian Pac. 
J. Health Sci., 2018; 5(1):31-34.
Source of Support: Nil, Conflict of Interest: None declared.
